WEST PHARMACEUTICAL SERVICES, INC. Dividends Payable, Current
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Dividends Payable, Current of $15.80 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:DividendsPayableCurrent · last filed 2026-02-17
- 2025-12-31: Dividends Payable, Current $15.80M.
- 2024-12-31: Dividends Payable, Current $15.20M.
- 2023-12-31: Dividends Payable, Current $14.80M.
- 2022-12-31: Dividends Payable, Current $14.10M.
| Period end | Dividends Payable, Current |
|---|---|
| 2025-12-31 | $15.80M 10-K · filed 2026-02-17 |
| 2024-12-31 | $15.20M 10-K · filed 2026-02-17 |
| 2023-12-31 | $14.80M 10-K · filed 2026-02-17 |
| 2022-12-31 | $14.10M 10-K · filed 2025-02-18 |
| 2021-12-31 | $13.40M 10-K · filed 2024-02-20 |
| 2020-12-31 | $12.60M 10-K · filed 2023-02-21 |
| 2019-12-31 | $11.80M 10-K · filed 2022-02-22 |
| 2018-12-31 | $11.30M 10-K · filed 2021-02-23 |
| 2017-12-31 | $10.40M 10-K · filed 2020-02-24 |
| 2016-12-31 | $9.50M 10-K · filed 2019-02-28 |
| 2015-12-31 | $8.60M 10-K · filed 2018-02-26 |
| 2014-12-31 | $7.80M 10-K · filed 2017-02-28 |
| 2013-12-31 | $7.00M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |